{"id":"W4224750762","doi":"10.1007/s43441-022-00409-w","title":"Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases","year":2022,"lang":"en","type":"review","venue":"Therapeutic Innovation & Regulatory Science","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Canada","funders":"National Center for Advancing Translational Sciences; Rare Diseases Clinical Research Network; National Institutes of Health; Ministry of Health, Labour and Welfare; Patient-Centered Outcomes Research Institute; National Organization for Rare Disorders","keywords":"Drug development; Medicine; Clinical trial; Pharmacy; Orphan drug; Pandemic; Public health; Disease; Population; Intensive care medicine; Business; Drug; Family medicine; Environmental health; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty); Nursing; Pharmacology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009859718,0.000323222,0.0004606075,0.0003764751,0.0005175462,0.00006970624,0.0004707896,0.00007237597,0.00001218666],"category_scores_gemma":[0.0001228123,0.0003162518,0.00007159018,0.002143431,0.0001775587,0.00002436946,0.0002699383,0.00008590285,0.000001310815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002779418,"about_ca_system_score_gemma":0.003002751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":6.728313e-7,"about_ca_topic_score_gemma":0.000002392695,"domain_scores_codex":[0.9976841,0.0000739837,0.000585621,0.0007614707,0.0004077034,0.0004871087],"domain_scores_gemma":[0.9988348,0.00003034014,0.0003197359,0.0004420308,0.0002017855,0.0001713411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000006791595,0.00003574372,0.000191748,0.001576257,0.0000336809,2.481401e-7,0.0001328718,0.00003298303,0.00005085858,0.002461643,0.0002124392,0.9952647],"study_design_scores_gemma":[0.0001517145,0.00009419295,0.004707098,0.0001148654,0.00002991086,0.000009753222,0.0000893683,0.000006356158,0.00004746721,0.00006308596,0.994298,0.0003881267],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005729736,0.9824907,0.01002453,0.00008324983,0.0003964952,0.001099322,0.0001011858,0.00003662248,0.0000381732],"genre_scores_gemma":[0.03265044,0.9597361,0.00440705,0.00118549,0.0004323732,0.0007483792,0.0005470511,0.00007405196,0.0002190576],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9948766,"threshold_uncertainty_score":0.999929,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04255516405409542,"score_gpt":0.3741790676218467,"score_spread":0.3316239035677513,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}